Ironwood Pharmaceuticals to Host First Quarter 2021 Investor Update Call
April 22 2021 - 4:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it
will host its first quarter 2021 investor update conference call
and webcast at 8:30 a.m. Eastern Time on Thursday, May 6, 2021.
Individuals interested in participating in the call should dial
(833) 350-1432 (U.S. and Canada) or (647) 689-6932 (international)
using conference ID number and event passcode 8067476. To access
the webcast, please visit the Investors section of Ironwood’s
website at www.ironwoodpharma.com at least 15 minutes prior to the
start of the call to ensure adequate time for any software
downloads that may be required.
The call will be available for replay via telephone starting
Thursday, May 6, 2021 at approximately 11:30 a.m. Eastern Time,
running through 11:59 p.m. Eastern Time on May 20, 2021. To listen
to the replay, dial (800) 585-8367 (U.S. and Canada) or (416)
621-4642 (international) using conference ID number 8067476. The
archived webcast will be available on Ironwood’s website for 14
days beginning approximately one hour after the call has
completed.
About Ironwood Pharmaceuticals Ironwood Pharmaceuticals
(Nasdaq: IRWD) is a GI-focused healthcare company dedicated to
creating medicines that make a difference for patients living with
GI diseases. We discovered, developed and are commercializing
linaclotide, the U.S. branded prescription market leader for adults
with irritable bowel syndrome with constipation (IBS-C) or chronic
idiopathic constipation (CIC).
Ironwood was founded in 1998 and is headquartered in Boston,
Mass. For more information, please visit our website
at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210422005103/en/
Media and Investors: Meredith Kaya, 617-374-5082 Vice
President, Finance and Investor Relations
mkaya@ironwoodpharma.com
Investors: Matt Roache, 617-621-8395 Director, Investor
Relations mroache@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jul 2023 to Jul 2024